(5E, 7E)-4, 5, 6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5, 7-dienoate from Euclea crispa (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms. (29th January 2022)
- Record Type:
- Journal Article
- Title:
- (5E, 7E)-4, 5, 6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5, 7-dienoate from Euclea crispa (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms. (29th January 2022)
- Main Title:
- (5E, 7E)-4, 5, 6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5, 7-dienoate from Euclea crispa (L.) Inhibits Ovarian Cancer Cell Growth by Controlling Apoptotic and Metastatic Signaling Mechanisms
- Authors:
- Palanisamy, Chella Perumal
Cui, Bo
Zhang, Hongxia
Jayaraman, Selvaraj
Rajagopal, Ponnulakshmi
Veeraraghavan, Vishnu Priya - Other Names:
- Rethinam Senthil Academic Editor.
- Abstract:
- Abstract : Bioactive compound (5E, 7E)-4, 5, 6 trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyran-2-ylheptadeca-5, 7-dienoate (compound 2) was isolated from Euclea crispa ( E. crispa ) by the chromatographic methods. Further, the compound was confirmed by spectroscopic techniques such as ultraviolet-visible (UV/Vis) spectrometer, Fourier transform infrared (FTIR) spectrometer, and 1 H and 13 C nuclear magnetic resonance (NMR). Compound 2 exhibited a significant antioxidant activity with IC50 values. It restrained the auxesis of HO-8910 cells in a shot-dependent mode. CXCR4, HER2, and Akt proteins involved in cell proliferation and metastasis were found to be significantly reduced (p < 0.05 ). The protein that is responsible for the death of cells (Bcl-2 and Bcl-xL) was reduced (p < 0.05 ), while the protein expression of p53 and caspase-9 was increased (p < 0.05 ) in compound 2-treated HO-8910 cells. The results of molecular docking analysis showed the binding affinity with CXCR4 and HER2. Thus, compound 2 can serve as a promising chemotherapeutic agent for the intervention of ovarian cancer. The findings of this study conclude that compound 2 from E. crispa might work as a potential antioxidative and chemotherapeutic agent. The in vivo studies and attempts will pave way for this compound to be an effective drug hereafter.
- Is Part Of:
- Bioinorganic chemistry and applications. Volume 2022(2022)
- Journal:
- Bioinorganic chemistry and applications
- Issue:
- Volume 2022(2022)
- Issue Display:
- Volume 2022, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 2022
- Issue:
- 2022
- Issue Sort Value:
- 2022-2022-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-01-29
- Subjects:
- Bioinorganic chemistry -- Periodicals
Bioinorganic chemistry
Biochemistry
Inorganic Chemistry
Chemistry, Bioinorganic
Periodicals
572.51 - Journal URLs:
- https://www.hindawi.com/journals/bca/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=419&action=archive ↗ - DOI:
- 10.1155/2022/4464056 ↗
- Languages:
- English
- ISSNs:
- 1565-3633
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 20868.xml